| | Taking the Fight to Rare Cancers Beating rare cancers demands expertise in oncology and rare diseases. Our white paper shows how adaptive design, study committees, and cross-industry cooperation are fueling real progress. Premier Research. Built for Biotech℠ |
Today's Rundown With last phase 3 in the bag, Medicines Company's inclisiran poised for PCSK9 battle BioNTech guns for $250M raise at $4.5B valuation in IPO plan Deep Genomics reveals its program: The first AI-discovered drug candidate Amryt buys Aegerion via bankruptcy, adding sales to support R&D Sygnature Discovery moves U.S. office to life science mecca Kendall Square Medtronic takes its new surgery robot out for a spin with investor debut Novartis to put AveXis into protective custody after data manipulation scandal Featured Story | | | Wednesday, September 25, 2019 The Medicines Company wrapped up the phase 3 study for PCSK9 drug inclisiran, saying it cut "bad" cholesterol in patients with arterial plaque buildup. The biotech said the drug’s safety and efficacy were “at least as favorable” as in earlier trials. |
|
|---|
|
Top Stories Wednesday, September 25, 2019 BioNTech set the terms of its Nasdaq IPO. If BioNTech hits the midpoint of the range, it will raise $251 million (€228 million) at a $4.5 billion valuation, giving it the financial might to fund its broad clinical development pipeline. Wednesday, September 25, 2019 Deep Genomics uses artificial intelligence to discover new disease targets as well as the best compounds to drug them. It unveiled its first program, a genetic medicine for Wilson disease, which has no disease-modifying treatments. Wednesday, September 25, 2019 Amryt Pharma has completed the acquisition of Aegerion Pharmaceuticals. The deal, which comes after Aegerion filed for Chapter 11 bankruptcy, gives Amryt near-full control of two commercial drugs. Wednesday, September 25, 2019 Drug discovery company Sygnature Discovery is moving its U.S. office to Kendall Square, the heart of the Cambridge–Boston biotech hub in Massachusetts. Wednesday, September 25, 2019 Medtronic pulled back the curtain for a first peek at its new soft-tissue surgery robot, Hugo. Based on a modular and upgradeable design, the system includes an operating console, central tower and multiple, cart-based robotic arms. Tuesday, September 24, 2019 Big Pharma's traditional hands-off approach led to a serious credibility issue for Novartis as a data manipulation scandal has unfolded at gene therapy biotech AveXis. Going forward, Novartis says, it will be hands-off no longer. | | Congratulations to the Fierce 15 You have proven that great innovations are created with breakthrough science, insightful leaders and unwavering resolve. Thank you. And we look forward to helping you advance to your next milestone. |
Enrollment Showcase | | | October 23-25, 2019 | Chicago, IL | Presented by Biotech Primer BioImmersion: Biotech for the Non-Scientist is a three-day, in-depth course that delves into the scientific details on a broad number of biotechnology topics. Register today! |
|
|---|
|
Resources Sponsored by: ON24 Compare digital program performance and audience engagement among your life sciences peers. Sponsored by: Decision Resources Group Clinically Integrated Networks are vehicles for powerful IDNs to extend their influence into the physician sector and play a key role for IDNs trying to pave a path to becoming a self-contained healthcare ecosystem. Sponsored by: BioAnalytix, Inc. Download the White Paper and learn how detailed characterization can guide successful development of gene therapy products. Sponsored by: Reprints Desk, Inc. Slashing your R&D costs is easier than you think. Sponsored by: Roche and IQVIA A global landscape study of funding trends and innovations. Sponsored by: Blue Matter, strategic consultants in the life sciences White paper providing an overview of precision medicine in oncology, as well as a look ahead at future developments and keys to success for pharmaceutical and diagnostics companies. Sponsored by: Patheon, by Thermo Fisher Scientific Avoid potential risks to the patient as well as costly interruptions during development. Sponsored by: Outer Edge Technology Find out how outsourcing your IT requirements enhances the bottom line while creating strategic advantage. Sponsored by: Vineti Developing a cell therapy, gene therapy, or personalized cancer vaccine? Modern data management makes a critical difference in operational and regulatory outcomes. This whitepaper will help your team leverage the latest data strategies for success. Sponsored by: AlphaSense AI-powered research tools are making it easier to source confident healthcare market intelligence with accuracy and efficiency -- download now to learn more about improving your competitive research strategy. Sponsored by: Elemental Machines Your lab is talking to you, are you listening? Sponsored by: Frenova Want to be sure your renal research protocol design is fit for the real world? Sponsored by: Recro Gainesville Vetting CDMOs but unsure what to look for in prospective partners’ multiproduct facilities? Sponsored by: Accenture Clinical trials are one of the pharma industry’s most painful and costly processes. Read how technology could transform the trial process from nine years to a matter of hours. Sponsored by: Baxter BioPharma Solutions Check out Baxter BioPharma Solutions’ whitepaper to learn considerations and options for developing a product in a prefilled syringe. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. U.S. Healthcare Compliance Certificate Program October 14-17, 2019 | Newark, New Jersey European Healthcare Compliance Certificate Program October 21-25, 2019 | Paris, France BioBasics: Biotech For The Non-Scientist Oct 22-23, 2019 | San Diego, CA BioImmersion: Biotech for the Non-Scientist October 23-25, 2019 | Chicago, IL 4th FierceBiotech Drug Development Forum October 28-29, 2019 | Boston, MA Drug Development Immersion November 7-8, 2019 | Boston, MA Advanced Therapies: Immunotherapies, Cell Therapies and Gene Therapies November 15, 2019 | Boston, MA Drug Development Boot Camp® 2019 November 20-21, 2019 | Boston, MA | Register NOW and start Pre-Boot Camp Preparation! | 